Imaginary Worlds: The European Network for Health Technology Assessment (EUnetHTA) Recommendations for Health Economic Evaluations
暂无分享,去创建一个
[1] Great Expectations: Cost-Utility Models as Decision Criteria , 2016 .
[2] E Ernst,et al. Nonsense on Stilts: How to Tell Science from Bunk , 2011 .
[3] P. Langley. Supporting Formulary Decisions: The Discovery of New Facts or Constructed Evidence? , 2016 .
[4] Andrew H Briggs,et al. Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] P. Langley. Modeling Imaginary Worlds: Version 4 of the AMCP Format for Formulary Submissions , 2016 .
[6] J. Caro,et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[7] P. Langley. Validation of modeled pharmacoeconomic claims in formulary submissions , 2015, Journal of medical economics.
[8] J. Chamova,et al. European network for health technology assessment – EUnetHTA , 2013 .
[9] T. Broadbent,et al. Criticism and the Growth of Knowledge , 1972 .
[10] P. Langley. Sunlit Uplands: The Genius of the NICE Reference Case , 2016 .
[11] P. Langley. Na domhain shamhlaíochta: formulary submission guidelines in Ireland and the standards of normal science , 2016, Current medical research and opinion.
[12] P. Langley. Imaginary Worlds: Modeled claims for cost-effectiveness published in PharmacoEconomics January 2015 to December 2015 , 2016 .
[13] P. Langley. He Ao Pohewa: The PHARMAC Prescription for Pharmacoeconomic Analysis in New Zealand and the Standards of Normal Science , 2016 .
[14] Gideon Nave,et al. Evaluating replicability of laboratory experiments in economics , 2016, Science.
[15] Uwe Siebert,et al. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] M. Kendall,et al. The Logic of Scientific Discovery. , 1959 .
[17] K. Popper,et al. The Logic of Scientific Discovery , 1960 .